Sotorasib everest price in bangladesh

Sotorasib (Sotorasib) is a new type of targeted therapy drug that is a RAS mutation inhibitor. This class of drugs is specifically designed to combat mutations in the RAS gene, which are common in a variety of cancers and are closely related to tumor occurrence, development and the development of drug resistance.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive.

The cheaper ones are the generic drugs sold abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan, which is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs. The price of generic Everest drugs in Bangladesh is about more than 4,000 yuan.

The RASgene is a key protein that regulates growth and differentiation in normal cells. However, when theRASgene is mutated, its uncontrolled activity may lead to abnormal proliferation of cancer cells. By inhibiting the activity of mutated RAS protein, sotoracib is expected to block this abnormal signaling pathway, thereby inhibiting the growth and spread of tumors.

The development of sotoracib represents an innovation in cancer treatment because it targets a common and difficult-to-treat genetic mutation. The drug blocks the normal signal transduction function by binding to the RAS protein. It is specific and precise and can slow down the proliferation rate of tumor cells and promote the apoptosis of these abnormal cells.

Sotoracib is mainly suitable for cancers with RAS gene mutations, especially showing significant potential efficacy in cancer types such as pancreatic cancer, colorectal cancer and lung cancer. However, patients will need a detailed medical evaluation and physician consultation before using sotoraxib to determine the most appropriate treatment option.